Literature DB >> 16330025

Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression.

Mélanie Héroult1, Florence Schaffner, Hellmut G Augustin.   

Abstract

Eph receptors comprise the largest family of receptor tyrosine kinases. They are classified into an A family and a B family on the basis of the characteristic properties of the corresponding ephrin ligands which are either GPI-anchored peripheral membrane molecules (A class ephrins) or transmembrane molecules (B class ephrins). Eph receptors and ephrin ligands were originally identified as neuronal pathfinding molecules. Yet, gene targeting experiments in mice have identified the EphB/ephrinB system as critical and rate-limiting determinant of arterio-venous differentiation during embryonic vascular development. Identification of vascular EphB/ephrinB functions has in the last few years stimulated two emerging fields of vascular biology research, namely (1) the molecular analysis of the structural and functional mechanisms of arterio-venous differentiation, and (2) the molecular study of the commonalities between vascular and neuronal guidance and patterning mechanisms. This review summarizes the current understanding of vascular Eph receptor and ephrin ligand functions and provides an overview of emerging roles of the Eph/ephrin system in controlling tumor and vascular functions during tumorigenesis and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330025     DOI: 10.1016/j.yexcr.2005.10.028

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  69 in total

1.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

2.  Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesis.

Authors:  Jennifer E Saik; Daniel J Gould; Aakash H Keswani; Mary E Dickinson; Jennifer L West
Journal:  Biomacromolecules       Date:  2011-06-15       Impact factor: 6.988

Review 3.  In vitro models for the evaluation of angiogenic potential in bone engineering.

Authors:  Elisabetta Cenni; Francesca Perut; Nicola Baldini
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

4.  Specific and shared targets of ephrin A signaling in epidermal keratinocytes.

Authors:  Rebecca Walsh; Miroslav Blumenberg
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

5.  Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Authors:  Stamatios Theocharis; Jerzy Klijanienko; Constantinos Giaginis; Paraskevi Alexandrou; Efstratios Patsouris; Xavier Sastre-Garau
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

Review 6.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

7.  The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Authors:  Roy Barco; Laura B Hunt; Andrea L Frump; Christina B Garcia; Andrew Benesh; Robert L Caldwell; Josiane E Eid
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

8.  Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.

Authors:  Srinivas Duggineni; Sayantan Mitra; Roberta Noberini; Xiaofeng Han; Nan Lin; Yan Xu; Wang Tian; Jing An; Elena B Pasquale; Ziwei Huang
Journal:  Biochem Pharmacol       Date:  2012-12-17       Impact factor: 5.858

9.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

10.  Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice.

Authors:  Tatsuma Okazaki; Amy Ni; Peter Baluk; Oluwasheyi A Ayeni; Jennifer Kearley; Anthony J Coyle; Alison Humbles; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.